Loading data
PTRNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 2.5 bn USD | 1.8 bn USD | 1.37 bn USD |
| Cost of revenue | 1.41 bn USD | 1.01 bn USD | 765.2 m USD |
| Research and development expense | 46.29 m USD | 17.99 m USD | 14.64 m USD |
| Operating profit | 25.41 m USD | 87.18 m USD | 52.79 m USD |
| Profit before tax | -794 k USD | 91.24 m USD | 56.34 m USD |
| Income tax expense | -17.04 m USD | 23.38 m USD | 15.08 m USD |
| Net income (reported basis) | 16.25 m USD | 67.86 m USD | 41.26 m USD |
| Net income attributable to common shareholders | -156.61 m USD | 42.49 m USD | 19.83 m USD |
| Basic earnings per share | -1.36 USD/share | 0.47 USD/share | 0.22 USD/share |
| Diluted earnings per share | -1.36 USD/share | 0.47 USD/share | 0.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.